Detail
Článek
Web zdroj
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases

Václav Ceplecha, Kristína Řeháková, Corinne Lendon, Pavel Proks, Miša Škorič, Guy C. M. Grinwis, Barbora Hřibová, Miloš Vávra, Jana Lorenzová, Michal Crha

. 2018 ; 87 (3) : 231-240.

Jazyk angličtina Země Česko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19002071

The aim of the study was to assess serum hyaluronic acid (HA) and transforming growth factor beta 1 (TGF-β1) concentrations: 1) to differentiate hepatic fibrosis from other forms of liver disease, and 2) for the non-invasive staging of canine liver fibrosis. We also evaluated the association between serum HA concentration and the size of the shunt vessel as an indirect marker of decreased liver clearance in patients with single congenital vascular anomaly. Forty-one healthy client-owned dogs and forty dogs diagnosed with hepatobiliary disease were enrolled in the prospective study. Patients were divided into 4 subgroups: 1) congenital portosystemic shunts (CPSS); 2) parenchymal diseases (a. mild and moderate fibrosis, b. advanced fibrosis and cirrhosis); 3) hepatic neoplasia; 4) biliary tract disorders based on thorough clinical, ultrasound and histopathological examination. Serum HA and TGF-β1 concentrations were measured using ELISA. The HA concentration was significantly increased in patients with advanced liver fibrosis/cirrhosis (P < 0.001) and CPSS (P < 0.001) compared to healthy dogs. Using a cut-off HA concentration of 135.94 ng/ml, the sensitivity and specificity for diagnosis for advanced liver fibrosis/cirrhosis was 100% (95% CI, 50.6–100) and 90.8% (95% CI, 81.6–95.7), respectively. The TGF-β1 levels did not significantly differ among groups (P = 0.180). Negligible correlation was found between serum HA concentration and the size of portosystemic shunt vessel (rs = 0.07; P = 0.831). These findings suggest that serum HA concentration is a potential non-invasive biomarker for advanced liver fibrosis and/or cirrhosis in dogs. The utility of measuring serum concentration of TGF-β1 for diagnosing canine liver fibrosis was not supported.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19002071
003      
CZ-PrNML
005      
20210624004157.0
007      
cr|cn|
008      
190110s2018 xr d fs 000 0|eng||
009      
AR
024    7_
$a 10.2754/avb201887030231 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Ceplecha, Václav $7 _AN093165 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic
245    10
$a Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases / $c Václav Ceplecha, Kristína Řeháková, Corinne Lendon, Pavel Proks, Miša Škorič, Guy C. M. Grinwis, Barbora Hřibová, Miloš Vávra, Jana Lorenzová, Michal Crha
504    __
$a Literatura
520    3_
$a The aim of the study was to assess serum hyaluronic acid (HA) and transforming growth factor beta 1 (TGF-β1) concentrations: 1) to differentiate hepatic fibrosis from other forms of liver disease, and 2) for the non-invasive staging of canine liver fibrosis. We also evaluated the association between serum HA concentration and the size of the shunt vessel as an indirect marker of decreased liver clearance in patients with single congenital vascular anomaly. Forty-one healthy client-owned dogs and forty dogs diagnosed with hepatobiliary disease were enrolled in the prospective study. Patients were divided into 4 subgroups: 1) congenital portosystemic shunts (CPSS); 2) parenchymal diseases (a. mild and moderate fibrosis, b. advanced fibrosis and cirrhosis); 3) hepatic neoplasia; 4) biliary tract disorders based on thorough clinical, ultrasound and histopathological examination. Serum HA and TGF-β1 concentrations were measured using ELISA. The HA concentration was significantly increased in patients with advanced liver fibrosis/cirrhosis (P < 0.001) and CPSS (P < 0.001) compared to healthy dogs. Using a cut-off HA concentration of 135.94 ng/ml, the sensitivity and specificity for diagnosis for advanced liver fibrosis/cirrhosis was 100% (95% CI, 50.6–100) and 90.8% (95% CI, 81.6–95.7), respectively. The TGF-β1 levels did not significantly differ among groups (P = 0.180). Negligible correlation was found between serum HA concentration and the size of portosystemic shunt vessel (rs = 0.07; P = 0.831). These findings suggest that serum HA concentration is a potential non-invasive biomarker for advanced liver fibrosis and/or cirrhosis in dogs. The utility of measuring serum concentration of TGF-β1 for diagnosing canine liver fibrosis was not supported.
650    _2
$a psi $7 D004285
650    12
$a kyselina hyaluronová $x krev $7 D006820
650    12
$a transformující růstový faktor beta1 $x krev $7 D053773
650    _2
$a nemoci trávicího systému $x diagnóza $x klasifikace $x krev $x veterinární $7 D004066
650    _2
$a nemoci jater $x diagnóza $x klasifikace $x krev $x veterinární $7 D008107
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a jaterní cirhóza $x diagnóza $x krev $x veterinární $7 D008103
650    _2
$a prospektivní studie $7 D011446
650    _2
$a statistika jako téma $7 D013223
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a chronická hepatitida $x krev $x veterinární $7 D006521
650    _2
$a ELISA $7 D004797
650    _2
$a biopsie $x metody $7 D001706
650    _2
$a laparoskopie $x metody $7 D010535
650    _2
$a ROC křivka $7 D012372
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Řeháková, Kristína $7 xx0192118 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinical Laboratory, Brno, Czech Republic
700    1_
$a Lendon, Corinne $u Edith Cowan University, Research & Innovation, Joondalup, WA, Australia
700    1_
$a Proks, Pavel $7 _AN065817 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic; CEITEC - Central European Institute of Technology, Brno, Czech Republic
700    1_
$a Škorič, Miša, $d 1977- $7 mzk2011653513 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Department of Pathological Morphology and Parasitology, Brno, Czech Republic
700    1_
$a Grinwis, Guy C. M. $u University of Utrecht, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht, the Netherlands
700    1_
$a Hřibová, Barbora $7 xx0280714 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic
700    1_
$a Vávra, Miloš $7 _AN093164 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic
700    1_
$a Lorenzová, Jana $7 xx0158103 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic; CEITEC - Central European Institute of Technology, Brno, Czech Republic
700    1_
$a Crha, Michal $7 xx0158096 $u University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Small Animal Clinic, Brno, Czech Republic
773    0_
$t Acta veterinaria Brno $x 0001-7213 $g Roč. 87, č. 3 (2018), s. 231-240 $w MED00172332
856    41
$u https://actavet.vfu.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b online $y p $z 0
990    __
$a 20190110095454 $b ABA008
991    __
$a 20210624004156 $b ABA008
999    __
$a ok $b bmc $g 1366242 $s 1040201
BAS    __
$a 3 $a 4
BMC    __
$a 2018 $b 87 $c 3 $d 231-240 $i 0001-7213 $m Acta veterinaria Brno $x MED00172332
LZP    __
$c NLK189 $d 20210624 $a NLK 2019-01/pk

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...